Mittie Doyle
Insider Reports History
- Location
- South San Francisco, CA
- Signature
- /s/ Christopher Sullivan, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Mittie Doyle:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Avalo Therapeutics, Inc. | Chief Medical Officer | Common Stock | 3,622 | $65,240 | $18.01 | 06 Apr 2026 | Direct |
| Avalo Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 210,530 | 06 Apr 2026 | Direct | ||
| Cullinan Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 79,456 | 07 Aug 2025 | Direct | ||
| DICE Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | 09 Aug 2023 | Direct |
Insider Reports Filed by Mittie Doyle
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AVTX | Avalo Therapeutics, Inc. | 06 Apr 2026 | 3 | -$71,508 | 4 | Chief Medical Officer | 08 Apr 2026, 16:51 |
| AVTX | Avalo Therapeutics, Inc. | 01 Apr 2026 | 3 | -$10,864 | 4 | Chief Medical Officer | 03 Apr 2026, 15:13 |
| AVTX | Avalo Therapeutics, Inc. | 16 Mar 2026 | 5 | -$411,607 | 4 | Chief Medical Officer | 18 Mar 2026, 16:07 |
| AVTX | Avalo Therapeutics, Inc. | 26 Feb 2026 | 1 | $0 | 4 | Chief Medical Officer | 02 Mar 2026, 16:23 |
| AVTX | Avalo Therapeutics, Inc. | 10 Dec 2025 | 1 | -$4,153 | 4 | Chief Medical Officer | 12 Dec 2025, 16:18 |
| CGEM | Cullinan Therapeutics, Inc. | 07 Aug 2025 | 1 | $0 | 4 | Director | 08 Aug 2025, 17:30 |
| CGEM | Cullinan Therapeutics, Inc. | 07 Aug 2025 | 0 | $0 | 3 | Director | 08 Aug 2025, 17:30 |
| AVTX | Avalo Therapeutics, Inc. | 28 Jan 2025 | 1 | $0 | 4 | Chief Medical Officer | 30 Jan 2025, 17:20 |
| AVTX | Avalo Therapeutics, Inc. | 15 Jul 2024 | 1 | $0 | 4 | Chief Medical Officer | 16 Jul 2024, 16:23 |
| AVTX | Avalo Therapeutics, Inc. | 15 Jul 2024 | 0 | $0 | 3 | Chief Medical Officer | 16 Jul 2024, 16:17 |
| /report/000120919123045170-doyle-mittie-2023-08-09 | DICE Therapeutics, Inc. | 09 Aug 2023 | 1 | $0 | 4 | Director | 09 Aug 2023, 16:21 |
| /report/000120919122022056-doyle-mittie-2022-03-31 | DICE Therapeutics, Inc. | 31 Mar 2022 | 1 | $0 | 4 | Director | 01 Apr 2022, 18:27 |
| /report/000120919122022049-doyle-mittie-2022-03-24 | DICE Therapeutics, Inc. | 24 Mar 2022 | 0 | $0 | 3 | Director | 01 Apr 2022, 18:12 |